Grants

  • FNIH Trailblazer Prize for Clinician-Scientist

    Sponsor: Foundations for the National Institute of Health Due Date: March 29, 2019 Award: This $10,000 honorarium and prize celebrates the transformational work of clinician-scientists, whose research translates basic scientific observations into new...

    March 29
  • Pediatric Epilepsy Research Foundation (PERF) Scientific Grant

    Sponsor: Pediatric Epilepsy Research Foundation Due Date: April 1, 2019 Award: Supports clinical or basic science research by a child neurologist or developmental pediatrician early in his/her academic career. The selected investigator will receive a...

    April 1
  • Physician Scientist Fellowship

    Sponsor: Doris Duke Charitable Foundation Due Date: Opens in April Award: The Physician Scientist Fellowship consists of $100,000 for annual direct costs plus $10,000 (10 percent) for annual indirect costs for one or two years, depending on the ne...

    April 1
  • Cycle 2: Alzheimer’s Drug Discovery Foundation

    LOI DUE APRIL 12, 2019 Drug Discovery Program Seeks to fund promising preclinical drug discovery and biomarker development programs for Alzheimer’s disease, related dementias and cognitive aging. The ADDF typically supports one year of research...

    April 12
  • ADDF-Harrington Scholar Program

    Sponsor: Alzheimer’s Drug Discovery Foundation LOI due date: April 12, 2019 Full Application due date: July 19, 2019 Award: Proposals should show potential to advance discovery into meaningful therapeutics designed to treat, prevent, or slow A...

    April 12
  • CNF Neurodevelopmental Disabilities (NDD) Summer Research Scholarship

    Sponsor: Child Neurology Foundation Due Date: April 14, 2019 Award: Each year, the CNF offers one summer clinical research scholarship for a first- or second-year U.S. or Canadian medical student who has an interest in training as a child neurologist...

    April 14
  • Cycle 2: Whitehall Foundation Grants-in-Aids

    Sponsor: Whitehall Foundation, Inc. LOI Due Date: April 15, 2019 Application Due Date: September 1, 2019 Award:  Grants-in-Aid are awarded for a one-year period and do not exceed $30,000.

    April 15
  • Cycle 2: Whitehall Foundation Research Grants

    Sponsor: Whitehall Foundation, Inc. LOI Due Date: April 15, 2019 Application Due Date: September 1, 2019 Award: Research grants normally range from $30,000 to $75,000 per year for up to three years.

    April 15
  • Cycle 2: Broad PCORI Funding Announcements

    Sponsor: Patient-Centered Outcomes Research Institute LOI Due Date: May 29, 2019 by 5 pm ET Application Due Date: September 4, 2019 by 5 pm Award: Addressing Disparities; Assessment of Prevention, Diagnosis, and Treatment Options; and Improving Hea...

    May 29
  • Cycle 4: Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44)

    Sponsor: National Institutes of Health (multiple Institutes) LOI Due Date: July 7, 2019 Application Due Date: August 9, 2019 Award: Actual needs; applicants should rarely exceed up to $500,000 total cost per year for Phase I and up to $1,500,000 to...

    July 7
  • Cycle 3: Alzheimer’s Drug Discovery Foundation

    LOI DUE JULY 12, 2019 Drug Discovery Program Seeks to fund promising preclinical drug discovery and biomarker development programs for Alzheimer’s disease, related dementias and cognitive aging. The ADDF typically supports one year of research ...

    July 12
  • Cycle 3: Whitehall Foundation Grants-in-Aids

    Sponsor: Whitehall Foundation, Inc. LOI Due Date: October 1, 2019 Application Due Date: February 15, 2020 Award:  Grants-in-Aid are awarded for a one-year period and do not exceed $30,000.

    October 1
  • Cycle 3: Whitehall Foundation Research Grants

    Sponsor: Whitehall Foundation, Inc. LOI Due Date: October 1, 2019 Application Due Date: February 15, 2020 Award: Research grants normally range from $30,000 to $75,000 per year for up to three years.

    October 1
  • Cycle 4: Alzheimer’s Drug Discovery Foundation

    LOI DUE OCTOBER 11, 2019 Drug Discovery Program The Drug Discovery RFP supports novel drug programs and repurposed/repositioned programs. One year with potential for follow-on funding; average award is $150,000-$600,000 based on stage and scope of r...

    October 11
  • Rolling Basis: Alzheimer’s Drug Discovery Foundation

    PROPOSALS ACCEPTED ON A ROLLING BASIS ADDF/NIH Supports NIA and NINDS grant proposals in NIH format that were scored but not funded, which fall within our mission and research priorities. Conference Funding Supports scientific conferences that are re...

    December 31
View All Events